Restored archive. The original History Commons is no longer online; this is a read-only edition of its timelines. Content is licensed CC BY-NC-SA.

November 23, 1998: Merck Submits Application for Vioxx Approval to FDA

1998-11-23

Merck submits its New Drug Application (NDA 21-042) to the Food and Drug Administration (FDA) for Vioxx, which is intended to treat acute pain in adults, dysmenorrhea and osteoarthritis. The drug is supposed to cause fewer gastrointestinal problems than painkillers currently on the market. The NDA includes results from clinical studies that involved 5,400 subjects. [US Food and Drug Administration, 2005]